Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sun Pharmaceutical Industries has reported that the FDA has granted tentative approval for the company's abbreviated new drug application for its generic version of Eli Lilly and Company's Gemzar, gemcitabine injection.
Subscribe to our email newsletter
These generic gemcitabine injections are therapeutic equivalents of Eli Lilly’s Gemzar injections available in two strengths: 200mg and 1g single use vial. Gemcitabine is an anticancer agent, used singly or in combination with other anticancer agents.